Laura Sit

6.6k citations

29 papers · 3.4k · 2 hit papers · h-index 14

Impact in

Oncology top 1%
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
Family Practice top 5%

Papers in

Oncology 19
- Cancer survivorship and care 9
- Cancer Treatment and Pharmacology 7
- Cancer Immunotherapy and Biomarkers 3
Molecular Biology 7
- Angiogenesis and VEGF in Cancer 3

Co-authors: Ethan Basch (20 shared papers)Deborah Schrag (9 shared papers)M. Fruscione (10 shared papers)Thomas M. Atkinson (11 shared papers)Howard I. Scher (7 shared papers)Allison Barz Leahy (4 shared papers)Mark G. Kris (4 shared papers)Lauren J. Rogak (10 shared papers)
Journals: Journal of Clinical Oncology (8 papers)Cancer Research (7 papers)Pain Medicine (2 papers)Quality of Life Research (2 papers)Clinical Cancer Research (1 paper)
Partner nations: United States Thailand Malaysia

In The Last Decade

Laura Sit

28 papers receiving 3.3k citations

Laura Sit's Hit Papers

align trajectories log scale

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial 2015 · 1.7k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Journal of Clinical Oncology
2009 JNCI Journal of the National Cancer Institute

Peers

Countries citing papers authored by Laura Sit

Since Specialization

Citations

This map shows the geographic impact of Laura Sit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Sit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Sit more than expected).

Fields of papers citing papers by Laura Sit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Sit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Sit. The network helps show where Laura Sit may publish in the future.

Co-authors

The 25 scholars most cited alongside Laura Sit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Laura Sit Line = papers co-authored together Laura Sit links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial Journal of Clinical Oncology ·Ethan Basch, Allison M. Deal, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren J. Rogak, Antonia V. Bennett, Amylou C. Dueck, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Allison Barz Leahy, Paul J. Novotny, M. Fruscione, Jeff A. Sloan, Deborah Schrag Hit paper breakdown →	2015	1668
2	Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes JNCI Journal of the National Cancer Institute ·Ethan Basch, Xiaoyu Jia, Glenn Heller, Allison Barz Leahy, Laura Sit, M. Fruscione, Mark Appawu, Alexia Iasonos, Thomas M. Atkinson, Shari Goldfarb, Ann Culkin, Mark G. Kris, Deborah Schrag Hit paper breakdown →	2009	480
3	Using Confirmatory Factor Analysis to Evaluate Construct Validity of the Brief Pain Inventory (BPI) Journal of Pain and Symptom Management ·Thomas M. Atkinson, Barry Rosenfeld, Laura Sit, Tito R. Mendoza, M. Fruscione, Dawn Lavene, Mary Shaw, Yuelin Li, Jennifer L. Hay, Charles S. Cleeland, Howard I. Scher, William Breitbart, Ethan Basch	2010	185
4	Reliability of adverse symptom event reporting by clinicians Quality of Life Research ·Thomas M. Atkinson, Yuelin Li, Charles W. Coffey, Laura Sit, Mary Shaw, Dawn Lavene, Antonia V. Bennett, M. Fruscione, Lauren J. Rogak, Jennifer L. Hay, Mithat Gönen, Deborah Schrag, Ethan Basch	2011	168
5	The Brief Pain Inventory and Its “Pain At Its Worst in the Last 24 Hours” Item: Clinical Trial Endpoint Considerations Pain Medicine ·Thomas M. Atkinson, Tito R. Mendoza, Laura Sit, Steven D. Passik, Howard I. Scher, Charles S. Cleeland, Ethan Basch	2009	163
6	PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE) Value in Health ·Ethan Basch, Bryce B. Reeve, Charles S. Cleeland, Joshua A. Sloan, Deborah Schrag, TM Atkinson, Tito R. Mendoza, John F. Hay, Amy P. Abernethy, Lori M. Minasian, Virginia E. Kwitkowski, AM Trentacosti, Lea Burke, Laura Sit, Deborah Watkins Bruner	2010	149
7	Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment Clinical Cancer Research ·Michael L. Maitland, Kristen Kasza, Theodore Karrison, Kristin Moshier, Laura Sit, Henry R. Black, Samir D. Undevia, Walter M. Stadler, W.J. Elliott, Mark J. Ratain	2009	124
8	Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Quality of Life Research ·(unknown), Jennifer L. Hay, Thomas M. Atkinson, Bryce B. Reeve, Sandra A. Mitchell, Tito R. Mendoza, Gordon Willis, Lori M. Minasian, Steven B. Clauser, Andrea Denicoff, Ann M. O’Mara, Alice Chen, Antonia V. Bennett, Diane Β. Paul, Joshua J. Gagne, Lauren J. Rogak, Laura Sit, Vish Viswanath, Deborah Schrag, Ethan Basch	2013	121
9	Feasibility of Long-Term Patient Self-Reporting of Toxicities From Home via the Internet During Routine Chemotherapy Journal of Clinical Oncology ·Timothy J. Judson, Antonia V. Bennett, Lauren J. Rogak, Laura Sit, Allison Barz Leahy, Mark G. Kris, CliffordA. Hudis, Howard I. Scher, Paul Sabattini, Deborah Schrag, Ethan Basch	2013	115
10	Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Translational Behavioral Medicine ·Deborah Watkins Bruner, Laura J. Hanisch, Bryce B. Reeve, Andy Trotti, Deborah Schrag, Laura Sit, Tito R. Mendoza, Lori M. Minasian, Ann M. O’Mara, Andrea Denicoff, Julia H. Rowland, Michael Montello, Cindy Geoghegan, Amy P. Abernethy, Steven B. Clauser, Kathleen M. Castro, Sandra A. Mitchell, Laurie B. Burke, Ann Marie Trentacosti, Ethan Basch	2011	64
11	Electronic Toxicity Monitoring and Patient-Reported Outcomes The Cancer Journal ·Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell, Stephen B. Clauser, Lori M. Minasian, Laura Sit, Ram Chilukuri, Paul Baumgartner, Lauren J. Rogak, Emily Blauel, Amy P. Abernethy, Deborah Watkins Bruner	2011	43
12	Prevalence of Pain and Analgesic Use in Men With Metastatic Prostate Cancer Using a Patient-Reported Outcome Measure Journal of Oncology Practice ·Karen A. Autio, Antonia V. Bennett, Xiaoyu Jia, M. Fruscione, Tomasz M. Beer, Daniel J. George, Michael A. Carducci, Christopher J. Logothetis, Robert C. Kane, Laura Sit, Lauren J. Rogak, Michael J. Morris, Howard I. Scher, Ethan Basch	2013	23
13	Measurement of Affective and Activity Pain Interference Using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903 Pain Medicine ·Thomas M. Atkinson, Susan Halabi, Antonia V. Bennett, Lauren J. Rogak, Laura Sit, Yuelin Li, Ellen B. Kaplan, Ethan Basch, (unknown)	2012	20
14	Software for Administering the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study JMIR Human Factors ·Martin W. Schoen, Ethan Basch, Lori L. Hudson, Arlene E. Chung, Tito R. Mendoza, Sandra A. Mitchell, Diane St. Germain, Paul Baumgartner, Laura Sit, Lauren J. Rogak, Marwan Shouery, Eve Shalley, Bryce B. Reeve, Maria Fawzy, Nrupen A. Bhavsar, Charles S. Cleeland, Deborah Schrag, Amylou C. Dueck, Amy P. Abernethy	2018	19
15	Sexual dysfunction in women with breast cancer: Prevalence and severity Journal of Clinical Oncology ·Shari Goldfarb, Maura N. Dickler, Laura Sit, M. Fruscione, Thomas Barz, Thomas M. Atkinson, Clifford A. Hudis, Ethan Basch	2009	10
16	Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC). Journal of Clinical Oncology ·Christine Nichols, Sandra A. Mitchell, Kathy Lang, Victoria Federico, Kathleen M. Castro, Lauren J. Rogak, Deepa Lalla, Steven B. Clauser, Bryce B. Reeve, Andrea Denicoff, Alice P. Chen, Richard Piekarz, Thomas M. Atkinson, Musa Mayer, Melissa Brammer, Laura Sit, Ann M. O’Mara, Lori M. Minasian, Ethan Basch	2012	10
17	Effects of Vascular Endothelial Growth Factor Signaling Inhibition on Human Erythropoiesis The Oncologist ·Sumita Bhatta, Kristen Wroblewski, Kelly L. Agarwal, Laura Sit, Ezra E.W. Cohen, Tanguy Y. Seiwert, Theodore Karrison, George L. Bakris, Mark J. Ratain, Everett E. Vokes, Michael L. Maitland	2013	9
18	Fasting glucose and triglycerides as biomarkers of mTOR inhibition, evidence of a categorical response. Journal of Clinical Oncology ·Anitha Nallari, Theodore Karrison, Gerd Rosner, Matthew R. Levine, Laura Sit, Kana Wu, Walter M. Stadler, Mark J. Ratain, Ezra E.W. Cohen, Michael L. Maitland	2010	6
19	Abstract P5-13-12: Immune signatures and MammaPrint (ultra) high risk class (MP2) as predictors of response to pembrolizumab combined with the TLR9 agonist SD101 in the neoadjuvant I-SPY 2 TRIAL Cancer Research ·Denise M. Wolf, Christina Yau, Michael J. Campbell, Hatem Soliman, Mark Jesus M. Magbanua, Ruixiao Lu, Nicholas O’Grady, Lamorna Brown Swigart, Gillian L. Hirst, Laura Sit, Yvonne M Florence, (unknown), Smita Asare, Douglas Yee, Angie DeMichele, Don Berry, Laura J. Esserman, Jo Chien, Laura van ‘t Veer	2022	2
20	Confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). Journal of Clinical Oncology ·Thomas M. Atkinson, Laura Sit, Tito R. Mendoza, M. Fruscione, Dawn Lavene, Merville C. Shaw, William Breitbart, Barry Rosenfeld, C. S. Cleeland, Ethan Basch	2010	2

About Laura Sit

Laura Sit is a scholar working on Oncology, Molecular Biology, Anesthesiology and Pain Medicine, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 29 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer survivorship and care (9 papers), Cancer Treatment and Pharmacology (7 papers), Pain Management and Opioid Use (6 papers), Patient-Provider Communication in Healthcare (3 papers), Endometrial and Cervical Cancer Treatments (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Musculoskeletal pain and rehabilitation (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Oncology (1.9k citations), Family Practice (78 citations), Pediatrics, Perinatology and Child Health (691 citations), Otorhinolaryngology (148 citations) and Public Health, Environmental and Occupational Health (915 citations). Laura Sit has collaborated with scholars based in United States, Thailand and Malaysia. Frequent co-authors include Ethan Basch, Deborah Schrag, M. Fruscione, Thomas M. Atkinson, Howard I. Scher, Allison Barz Leahy, Mark G. Kris, Lauren J. Rogak, Antonia V. Bennett and Amylou C. Dueck. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Pain Medicine, Quality of Life Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Laura Sit

Impact in

Papers in i

In The Last Decade

Laura Sit

Laura Sit's Hit Papers

Peers

Countries citing papers authored by Laura Sit

Fields of papers citing papers by Laura Sit

All Works

About Laura Sit

Explore authors with similar magnitude of impact

Papers in